相关实验视频

Updated: Sep 16, 2025

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

多发性骨髓瘤中CAR治疗的目标

Olga A Bezborodova¹, Galina V Trunova¹, Elena R Nemtsova¹

¹Moscow Hertsen Research Institute of Oncology-Branch of the National Medical Radiology Research Center, Ministry of Health of the Russian Federation, Moscow 125284, Russia.

International journal of molecular sciences

|July 12, 2025

概括

化学抗原受体 (CAR) T细胞疗法对多发性骨髓瘤 (MM) 是有前途的. 优化目标选择和采用先进的生物工程策略对于增强CAR T细胞治疗至关重要.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
生物技术是生物技术.

背景情况:

多发性骨髓瘤 (MM) 是一种复杂的B细胞恶性瘤,其特征是高复发率和耐药性.
目前的标准疗法有效性有限,因此需要新的治疗方法.
化学抗原受体 (CAR) T细胞疗法已成为复发性和耐火性MM的有希望的策略.

研究的目的:

审查和分析多发性骨髓瘤的CAR T细胞治疗点.
评估CAR细胞产品的生物特性,表达模式和临床发展.
探索克服挑战的策略,例如在MM的CAR T细胞疗法中抗原逃逸.

主要方法:

在MM中对CAR T细胞治疗点的综合文献综述.
对各种CAR结构的生物特征和临床数据的分析.
评估先进的方法,如多特异性CAR和安全系统.

主要成果:

鉴定和分析了MM的众多CAR T细胞点,包括BCMA,GPRC5D,FcRH5,SLAMF7,CD38等.
强调了目标选择性,稳定表达和生物相关性的重要性.
讨论了减轻抗原逃逸的策略,例如多特异性CAR和受控激活.

结论:

目标的合理选择和创新的生物工程对于有效的CAR T细胞治疗在MM中至关重要.
将分子目标洞察与先进的工程解决方案相结合,将提高有效性,耐用性和安全性.
卡尔T细胞疗法具有显著的潜力,可以改善复发性和耐火性多发性髓瘤的结果.

关键词:

这是CAR-NK.在CART-T中,我们可以使用CAR-T.抗原逃逸的方法是什么?细胞疗法是细胞疗法.免疫疗法免疫疗法这是逻辑激活的逻辑激活.多种特异性的CAR.多发性骨髓瘤是多发性骨髓瘤的一种疾病.治疗的安全性治疗的安全性瘤的目标是瘤的目标.

更多相关视频

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...